⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Gyre Therapeutics, Inc. Common Stock

$7.08
-0.28 (-3.80%)

Volume:

120.008K ($849.66K)

Market Capitalization:

$789.49M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Gyre Therapeutics Market Segments

After Hours

+0.00(+0.00%)
Open$7.08
Close$7.08
Low$7.08
Low Change0.00 (0.00%)
High$7.08
High Change+0.00 (+0.00%)
Range$0.00
Volume20.131K
Dollar Volume$142.53K

Regular Trading Hours

-0.34(-4.58%)
Open$7.42
Close$7.08
Low$7.01
Low Change-0.41 (-5.53%)
High$7.42
High Change+0.00 (+0.00%)
Range$0.41
Volume99.877K
Dollar Volume$707.13K

Premarket

*No Trades in Segment

Overnight

*No Trades in Segment

After Hours Yesterday

+0.04(+0.54%)
Open$7.35
Close$7.39
Low$7.35
Low Change0.00 (0.00%)
High$7.39
High Change+0.04 (+0.54%)
Range$0.04
Volume108.085K
Dollar Volume$798.75K

Regular Trading Hours Yesterday

+0.19(+2.65%)
Open$7.17
Close$7.36
Low$7.09
Low Change-0.08 (-1.18%)
High$7.43
High Change+0.26 (+3.63%)
Range$0.34
Volume62.39K
Dollar Volume$459.19K

Premarket Yesterday

*No Trades in Segment

Gyre Therapeutics Top Trades

Gyre Therapeutics's top trade so far today returned +1.00%, while the top short trade returned -5.53%.

Gyre Therapeutics Moving Averages

5 Day Moving Average (SMA5)$7.22
10 Day Moving Average (SMA10)$7.32
20 Day Moving Average (SMA20)$7.16
50 Day Moving Average (SMA50)$6.76
100 Day Moving Average (SMA100)$6.51
200 Day Moving Average (SMA200)$7.08

Gyre Therapeutics Statistics

Average Volume (30 Days)154.4K
P/E Ratio (Current)-41.82
EPS (Current)-$0.17
Dividend Yield0.00%
Free Cash Flow-$15.75M
Cash Ratio1.51
Current Ratio4.26
Quick Ratio3.86
Debt to Equity0.00
Enterprise Value$710.61M
EV to EBITDA-53.94
EV to Sales5.95
Price to Book6.99
Price to Cash Flow—
Price to Free Cash Flow—
Price to Sales6.31
Return on Assets-0.09%
Return on Equity-0.17%

Gyre Therapeutics Stock Splits

There have been 2 stock splits for Gyre Therapeutics (GYRE). The last stock split occured on January 13, 2023 and increased the outstanding shares at a ratio of 1:2.

DateTypeRatio
Jan 13, 2023Forward1:2
Feb 13, 2017Reverse15:1

Gyre Therapeutics Dividends

There have been no dividends for Gyre Therapeutics (GYRE).